Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GSK Names Former Sanofi Executive As President Of Japanese Affiliate

This article was originally published in PharmAsia News

Executive Summary

GlaxoSmithKline has appointed Philippe Fauchet, formerly a senior vice president at Sanofi-Aventis, as the new president of GSK's Japanese subsidiary

You may also be interested in...

GSK Files Japan's First Rotavirus Vaccine; Will Japan Become Next Battleground For Vaccine Makers?

GlaxoSmithKline announced Nov. 30 it is applying for approval for its rotavirus vaccine Rotarix with Japan's Ministry of Health, Labor and Welfare. If approved, it will become the first vaccine in Japan to prevent rotavirus gastroenteritis, a leading cause of diarrhea-related deaths in children

GSK Wins Japanese Approval For Cervarix As First Cervical Cancer Vaccine In Japan

TOKYO - GlaxoSmithKline K.K., the fully-owned Japanese subsidiary of GlaxoSmithKline, has won Japan's Ministry of Health, Labor and Welfare approval for cervical cancer vaccine Cervarix, the first cervical cancer vaccine to be marketed in Japan, the company announced Oct. 16

GSK Sees Emerging Market Opportunity In Thinking Locally, Developing Locally

SINGAPORE - GSK APJEM R&D is pretty hefty as far as acronyms go, but GlaxoSmithKline's Judith Hills wants to make sure observers do not over look the research and development title in the new GSK division




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts